|
Gene Vaccines
* x) L6 {5 |0 W* w; FThalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.)6 }6 y( }0 m1 j4 y
1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.
/ l& a$ Y4 Y% u4 r6 w7 ~8 O# s9 u6 k/ W7 ]
Hardcover, ISBN 978-3-7091-0438-57 C: _3 c! i* t
Online orders shipping within 2-3 days
, I2 k" }1 m+ o8 p: n( E4 ]149,95 5 u4 J: b$ R* Y
4 @6 v1 M( B* r0 `1 {( I4 N2 ^ Z目录
/ T+ F( ?( X5 F% @- R6 S/ UPreface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.
. J$ I" F+ u U8 m$ J* ]7 T5 F1 o y( b" \4 q2 E0 u) t
下载地址:. b3 e B# t5 P+ `/ Q
8 w$ U7 K" e2 H/ ~5 K& c4 R2 F# y0 u5 S4 e
|
|